膀胱癌机器人辅助根治性膀胱切除术后达成五联征的肿瘤学结局:多中心KORARC数据库分析
基于KORARC多中心数据库730例RARC患者,208例(28.5%)达成五联征。中位随访31.1个月,达成组10年OS(70.4% vs 58.1%,P=0.016)与CSS(87.8% vs 70.0%,P=0.036)均显著更优;多因素分析显示五联征是全因死亡的显著预测因子(HR 0.561,P=0.038)。
要点
- RARC五联征达成率28.5%,达成者10年OS与CSS显著更优。
- 五联征是全因死亡的独立预测因子(HR 0.561,P=0.038)。
- 五联征可用于标准化评估RARC手术质量。
核心结论
- 达成RARC五联征的患者生存结局显著优于未达成者。
- 五联征可用于标准化评估RARC的手术质量。
研究设计与样本
- 基于KORARC数据库(12个中心)的前瞻性收集、回顾性分析。
- 纳入2007年4月至2019年5月接受RARC的730例膀胱癌患者。
主要发现
- 730例中208例(28.5%)达成五联征,522例(71.5%)未达成。
- 达成组10年OS为70.4%,未达成组为58.1%(P=0.016)。
- 达成组10年CSS为87.8%,未达成组为70.0%(P=0.036)。
- 多因素分析显示五联征是全因死亡的显著预测因子(HR 0.561,P=0.038)。
- 达成组更多接受新膀胱(P=0.039)、更常采用体内技术(P<0.001)、手术时间(P=0.020)和控制台时间(P=0.021)更长。
关键数值与推荐
- 五联征定义:切缘阴性、清扫淋巴结≥16枚、90天内无Clavien-Dindo 3-5级重大并发症、术后12个月内无临床复发、无输尿管肠吻合口狭窄。
临床怎么用
- 可将五联征作为RARC手术质量的标准化评估工具。
- 达成五联征与更优的肿瘤学结局相关,提示围手术期质量改进的潜在价值。
局限性
- 需要独立队列研究来验证本结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the oncological significance of a robot-assisted radical cystectomy (RARC)-related pentafecta in patients with bladder cancer. PATIENTS AND METHODS: Using the KORARC database, which includes data from 12 centres, data from 730 patients who underwent RARC between April 2007 and May 2019 were prospectively collected and retrospectively analysed. Pentafecta was achieved if patients met all of the following criteria: (i) negative soft tissue surgical margin; (ii) ≥16 lymph nodes removed; (iii) no major complications (Clavien-Dindo grade 3-5) within 90 days; (iv) no clinical recurrence within the first 12 months; and (v) no ureteroenteric stricture. Patients were divided into two groups according to pentafecta attainment, and a comparison of overall survival (OS) and cancer-specific survival (CSS) using multivariate Cox proportional analysis was then carried out. RESULTS: Of the 730 patients included in this analysis, 208 (28.5%) attained the RARC pentafecta; the remaining 522 (71.5%) did not. The mean age of the patients was 64.67 years, 85.1% were men, 53.6% received a conduit, 37.7% received orthotopic neobladders and the total complication rate was 57.8%. Those who attained the pentafecta received more neobladders (P = 0.039), were more likely to be treated with the intracorporeal technique (P < 0.001), had longer operating times (P = 0.020) and had longer console time (P = 0.021) compared with those who did not attain the pentafecta. Over a mean of 31.1 months of follow-up, the pentafecta attainment group had significantly higher OS and CSS rates compared with the non-attainment group (10-year OS 70.4% vs 58.1%, respectively [P = 0.016]; 10-year CSS 87.8% vs 70.0%, respectively [P = 0.036]). Multivariate analysis showed that the RARC pentafecta was a significant predictor of overall mortality (hazard ratio 0.561; P = 0.038). CONCLUSIONS: Patients who attained the RARC pentafecta had significantly better survival outcomes compared with those who did not. These criteria could be used to standardize assessment of the surgical quality of RARC. In the future, a similar study using an independent cohort is warranted to confirm our results.
引用
- Oh JJ, Lee S, Ku JH, et al. Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database. BJU Int. 2020. PMID: 32682331. doi:10.1111/bju.15178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。